Clinical Trial Update: Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the efficacy and safety of Bmab 1200 versus Stelara (ustekinumab) in adults with moderate-to-severe chronic plaque psoriasis has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bmab 1200
• Stelara (ustekinumab)

Snippet

Sponsor: Biocon Biologics UK Ltd | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2025-09-12